Single- and multiple-dose pharmacokinetics, safety, and tolerability of Aripiprazole once-monthly, long-acting intramuscular injection for Chinese adults with schizophrenia
Abstract Background Aripiprazole once-monthly (AOM), a long-acting injectable antipsychotic, is increasingly used in managing schizophrenia. However, to date, there has been no disclosure of pharmacokinetic data for AOM long-acting injection in the Chinese population. The present study aimed to eval...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BMC
2025-10-01
|
| Seri Bilgileri: | BMC Psychiatry |
| Konular: | |
| Online Erişim: | https://doi.org/10.1186/s12888-025-07407-w |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|